Roman-Trufero, M; Blighe, K; Zebisch, A; Perfler, B; Herzog, SA; Butt, R; Auner, H; Clemo, N.
Nonclinical evaluation of APL-4098, a novel GCN2 kinase inhibitor, reveals potent anti-leukemic effects through mitochondrial stress induction and synergy with venetoclax, targeting AML blasts and LSCs
BLOOD. 2025; 146: 1503-1504.
Doi: 10.1182/blood-2025-1503
[Poster]
Web of Science
FullText
FullText_MUG